A recent FDA warning regarding the popular diabetes medication Actos has set off a general concern among patients who have experienced serious side effects and have driven many individuals to file an Actos lawsuit.
Reason for the Actos lawsuit
Actos, also known as pioglitazone, is the latest in a class of type 2 diabetes drugs known as thiazolidinediones (TZD) to be linked with dangerous side effects such as bladder cancer, heart failure, heart attack, liver damage, limb fracture, and even death. In August 2011, the FDA issued a warning to the public about harmful side effects, including the increased risk of Actos bladder cancer in patients who take the drug for 12 months or more.
If you or a loved one has experienced serious Actos side effects — including bladder cancer or heart failure — you may be eligible to seek compensation for your pain, suffering, and medical costs by filing an Actos lawsuit. Eligible patients and their loved ones are urged to contact one of our experienced Actos lawyers and to evaluate a possible claim against the manufacturer.
Free Actos lawsuit consultation
An Actos lawsuit case evaluation is free. Our Actos lawyers will review the unique circumstances surrounding each person’s experience with the medication by asking questions such as:
- When was the drug prescribed and taken, and for how long?
- What Actos side effects did you or your loved one develop? Actos bladder cancer? Heart failure?
- When did the side effects develop? During the period of Actos use? After?
- When did the patient become aware that his or her symptoms might be an injurious result of the drug?
Compensation for Actos side effects
An Actos lawsuit evaluation will also include a review the damages you or your loved one has sustained as a result of the injury or illness. You may be entitled to compensation for:
- Medical expenses (past, present, and future)
- Lost income and earning capacity
- Pain and suffering
- Loss of enjoyment of life
- Loss of consortium
- Emotional distress
- Wrongful death
- Failure to warn
Patients who developed serious injuries from the two previous TZD drugs to come under fire from the FDA — Rezulin and Avandia — have already reached settlements with the drug makers. The number of plaintiffs who have filed an Actos lawsuit has grown steadily over the past year, and Actos settlement amounts, particularly in cases of patients suffering from bladder cancer, could be significant.
Actos bladder cancer recall, warning
In June 2011, France’s drug regulatory agency suspended the use of Actos due to study findings pointing to a high risk of Actos bladder cancer.
Later that same month, the FDA raised its own concerns about Actos bladder cancer by issuing a warning about the increased risk of the disease for patients using the drug for a year or more. The FDA urges that patients with active bladder cancer, or a prior history of the disease, not be prescribed the drug.
Additionally, the FDA requests that any patients taking a pioglitazone-containing drug alert their physicians if they show signs of Actos side effects such as blood in the urine, red urine, abnormal frequency of urination, or sharp pains during urination.
The FDA had previously released a safety advisory in 2007 alerting the public to an increased risk of heart failure, potentially resulting in heart attack and even death, in patients taking Actos. Particularly at risk are patients with a pre-existing history of heart disease, or patients confined to a bed or wheelchair.
Filing an Actos lawsuit
If you or a loved one is eligible to file an Actos lawsuit, one of our experienced Actos lawyers will guide you through the intricacies of pharmaceutical litigation. Complex questions of law include statute of limitations considerations, whether to file an Actos class action lawsuit, how to handle a potential transfer to multidistrict litigation (“Actos MDL”), and how to comply with discovery and courtroom procedure. An Actos lawyer can also play a vital role in pre-suit negotiations and may help procure a favorable Actos lawsuit settlement without having to resort to trial at all.
The outcome of a hearing held on December 1, 2011 before a panel of federal judges will play a critical role for future Actos bladder cancer lawsuits, as the JPML deliberates the pending motion to form an Actos MDL. If the Actos litigation is consolidated in this manner, litigants may enjoy a more swift resolution to their individual Actos lawsuit.